Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... [Yahoo! Finance]
Aquestive Therapeutics, Inc. (AQST)
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.aquestive.com/investor-relations
Company Research
Source: Yahoo! Finance
Research and Development Expenses: Increased to $5.3 million in Q3 2024 from $3.2 million in Q3 2023. Selling, General, and Administrative Expenses: Increased to $12.1 million in Q3 2024 from $7.4 million in Q3 2023. Net Loss: $11.5 million in Q3 2024, or $0.13 per share, compared to $2 million in Q3 2023, or $0.03 per share. Non-GAAP Adjusted EBITDA Loss: $6.6 million in Q3 2024 compared to $1.3 million in Q3 2023. Cash and Cash Equivalents: $77.9 million as of September 30, 2024. 2024 Revenue Guidance: Approximately $57 million to $60 million. 2024 Non-GAAP Adjusted EBITDA Loss Guidance: Approximately $20 million to $23 million. Warning! GuruFocus has detected 5 Warning Signs with AQST. Release Date: November 05, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Aquestive Therapeutics Inc ( NASDAQ:AQST ) announced a major new product candidate, AQST-108, for alopecia areata, expanding their pipeline. The c
Show less
Read more
Impact Snapshot
Event Time:
AQST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AQST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AQST alerts
High impacting Aquestive Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AQST
News
- Aquestive Therapeutics to Participate in Two Upcoming Investor ConferencesGlobeNewswire
- Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.MarketBeat
- Aquestive Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]Yahoo! Finance
- Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]Yahoo! Finance
- Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
AQST
Earnings
- 11/4/24 - Miss
AQST
Sec Filings
- 11/8/24 - Form SC
- 11/7/24 - Form 8-K
- 11/6/24 - Form 8-K
- AQST's page on the SEC website